0.4426
前日終値:
$0.49
開ける:
$0.51
24時間の取引高:
927.39K
Relative Volume:
0.43
時価総額:
$62.66M
収益:
-
当期純損益:
$-119.76M
株価収益率:
-0.3279
EPS:
-1.35
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
-6.80%
1か月 パフォーマンス:
+36.69%
6か月 パフォーマンス:
-18.74%
1年 パフォーマンス:
-91.22%
Applied Therapeutics Inc Stock (APLT) Company Profile
名前
Applied Therapeutics Inc
セクター
電話
212-220-9226
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
APLT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
APLT
Applied Therapeutics Inc
|
0.4426 | 69.37M | 0 | -119.76M | -55.17M | -1.35 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-12-23 | ダウングレード | William Blair | Outperform → Mkt Perform |
2024-12-02 | ダウングレード | UBS | Buy → Neutral |
2024-11-29 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2024-07-31 | 開始されました | William Blair | Outperform |
2024-03-26 | 開始されました | RBC Capital Mkts | Outperform |
2024-02-22 | 開始されました | Leerink Partners | Outperform |
2022-01-04 | ダウングレード | Barclays | Overweight → Equal Weight |
2021-08-27 | ダウングレード | Goldman | Neutral → Sell |
2021-06-25 | 再開されました | Goldman | Neutral |
2020-10-08 | 開始されました | Truist | Buy |
2020-04-22 | 開始されました | Goldman | Buy |
2020-02-27 | 開始されました | Barclays | Overweight |
2019-06-10 | 開始されました | Citigroup | Buy |
2019-06-10 | 開始されました | Cowen | Outperform |
2019-06-10 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Applied Therapeutics Inc (APLT) 最新ニュース
Wall Street Zen Upgrades Applied Therapeutics (NASDAQ:APLT) to Sell - MarketBeat
Published on: 2025-07-29 13:58:52 - metal.it
Why Applied Therapeutics Inc. stock attracts strong analyst attentionLow Capital High Return Stock Plans Reviewed - metal.it
APLT LAWSUIT ALERT: Levi & Korsinsky Notifies Applied Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
What catalysts could drive Applied Therapeutics Inc. stock higher in 2025Capitalize on proven investment strategies - jammulinksnews.com
What are analysts’ price targets for Applied Therapeutics Inc. in the next 12 monthsExponential return rates - jammulinksnews.com
Brokerages Set Applied Therapeutics Inc. (NASDAQ:APLT) PT at $6.10 - MarketBeat
How does Applied Therapeutics Inc. compare to its industry peersRemarkable growth - jammulinksnews.com
What institutional investors are buying Applied Therapeutics Inc. stockConsistent wealth multiplication - jammulinksnews.com
What are the latest earnings results for Applied Therapeutics Inc.Consistent triple-digit returns - jammulinksnews.com
What is Applied Therapeutics Inc. company’s growth strategyMaximize your portfolio’s growth potential - jammulinksnews.com
What are the technical indicators suggesting about Applied Therapeutics Inc.Capitalize on emerging market sectors - jammulinksnews.com
Applied Therapeutics (NASDAQ:APLT) Shares Down 5%Here's Why - MarketBeat
Is Applied Therapeutics Inc. a good long term investmentFree Consultation - PrintWeekIndia
Should I buy Applied Therapeutics Inc. stock before earningsFree Investment Risk Control - jammulinksnews.com
What drives Applied Therapeutics Inc. stock priceFastest-growing stock picks - Autocar Professional
What analysts say about Applied Therapeutics Inc. stockUnbelievable profit margins - PrintWeekIndia
Applied Therapeutics Inc. Stock Analysis and ForecastFree Stock Selection - Autocar Professional
How Applied Therapeutics Inc. stock reacts to Fed policy changesTop Analyst Picks - Newser
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire
Applied Therapeutics, Inc. shares rise 1.28% premarket after Intesa Sanpaolo invests in NUCLIDIUM's cancer radiotheranostics. - AInvest
What makes Applied Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser
How Applied Therapeutics Inc. stock performs during market volatilitySecure Your Capital Strategy - Newser
Applied Therapeutics Inc (APLT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):